HomeNGEN • CVE
Follow
NervGen Pharma Corp
Previous close
$2.18
Day range
$2.12 - $2.26
Year range
$1.50 - $3.98
Market cap
132.11M CAD
Avg Volume
112.89K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.42M | -30.62% |
Net income | -4.30M | -23.07% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.40M | 30.42% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 14.79M | -46.62% |
Total assets | 16.36M | -43.36% |
Total liabilities | 11.25M | 7.48% |
Total equity | 5.11M | — |
Shares outstanding | 59.51M | — |
Price to book | 24.22 | — |
Return on assets | -50.57% | — |
Return on capital | -130.11% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -4.30M | -23.07% |
Cash from operations | -1.43M | 70.28% |
Cash from investing | -138.46K | -2,320.19% |
Cash from financing | 72.38K | -99.64% |
Net change in cash | -1.30M | -108.08% |
Free cash flow | 794.40K | -83.26% |
About
Founded
2017
Headquarters
Website
Employees
10